LncRNA regulates breast cancer endocrine therapy resistance: LncRNA-UCA1 mediates Wnt / β-Catenin and AKT / mTOR signaling pathway promotes breast cancer endocrine therapy resistant [25]. This evidence concerns the gene MTOR and breast carcinoma.